RBC Capital lowered the firm’s price target on Acadia Healthcare (ACHC) to $19 from $22 and keeps an Outperform rating on the shares. The firm cites the company having disappointed with yet another downward guidance revision as Acadia underestimated its expected 2025 PLGL – professional and general liability – expenses, the analyst tells investors in a research note, adding that the management also expects liability expenses to remain elevated through 2026.
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge-fund level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ACHC:
- Acadia Healthcare price target lowered to $17 from $22 at Cantor Fitzgerald
- Acadia Healthcare price target lowered to $24 from $28 at UBS
- Leerink downgrades Acadia Healthcare on ‘real risk’ of legal liabilities
- Acadia Healthcare price target lowered to $25 from $30 at KeyBanc
- BofA downgrades Acadia Healthcare to Underperform after another guidance cut